CVS Health Corp.
CVS | NYSE
$90.24
-$0.09 (-0.10%)
At close: Oct 30, 2026, 3:59 PM ET
$90.33
+$0.09 (+0.10%)
Pre-market:
Nov 2, 2026, 4:41 AM ET
Market Data
Market Cap $115.41B
Enterprise Value $177.76B
Beta 0.60
Average Volume 7.81M
Shares Outstanding (Diluted) 1.28B
Shares Change YoY 1.02%
Institutional Ownership 90.23%
Exchange NYSE
ISIN US1266501006
Price Performance
Price Change 1M 5.3%
Price Change 3M -13.6%
Price Change 6M 9.9%
Price Change YTD 13.7%
Price Change 1Y 15.5%
Price Change 3Y 30.8%
Price Change 5Y 1.1%
1M CAGR (ann.) 2.3%
1Y CAGR (ann.) 15.4%
5Y CAGR (ann.) 4.0%
All-Time CAGR 3.9%
Valuation
PE Ratio 23.87
Forward PE 10.50
PEG Ratio 3.69
Forward PEG 1.14
PS Ratio 0.28
Forward PS 0.30
PB Ratio 1.45
P/FCF Ratio 7.61
P/Adj. FCF Ratio 7.92
P/OCF Ratio 7.79
EV/Sales 0.43
EV/EBIT 20.00
EV/EBITDA 14.47
EV/FCF 11.73
Earnings Yield 4.2%
FCF Yield 13.1%
Adj. FCF Yield 12.6%
Financial Health
Net Debt $47.45B
Total Debt $76.31B
Cash & Short-Term Investments $13.96B
Total Assets $253.77B
Current Ratio 0.87
Quick Ratio 0.66
Debt / Equity Ratio 0.96
Debt / EBITDA 6.21
Debt / FCF 5.03
OCF / Debt 0.25
Interest Coverage 2.67
Altman Z-Score 2.46
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 14.2%
Operating Profit Margin 2.0%
EBITDA Margin 3.2%
Net Profit Margin 1.2%
FCF Margin 3.6%
Adj. FCF Margin 3.5%
SBC / Revenue 0.1%
SBC Impact (per share) -3.8%
Returns
Return on Assets 1.9%
Return on Equity 6.4%
Return on Invested Capital 4.1%
Return on Capital Employed 5.0%
Return on Tangible Assets 3.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.0%
Revenue CAGR 5Y 8.3%
Revenue CAGR 10Y 9.6%
EPS CAGR 3Y 17.8%
EPS CAGR 5Y -7.1%
EPS CAGR 10Y -1.4%
FCF CAGR 3Y -5.0%
FCF CAGR 5Y 5.5%
FCF CAGR 10Y 8.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 17
EPS Growth Next 3Y 41.5%
Revenue Growth Next 3Y 4.6%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $1.65
EPS Growth Est (next Q) 3.1%
Revenue Est (next Q) $104.72B
Revenue Growth Est (next Q) 1.8%
Fair Value Estimates
Graham Number $72.98
Graham Upside -19.1%
Lynch Fair Value $18.90
Lynch Upside -79.1%
Price Target $111.25
Price Target Upside 23.3%
Cash Flow
Operating Cash Flow $19.03B
Free Cash Flow $15.16B
Adj. Free Cash Flow $14.58B
FCF Per Share $9.21
OCF Per Share $11.58
OCF/S Ratio 3.6%
Income Statement
Revenue $415.09B
Gross Profit $58.75B
Operating Income $8.29B
EBITDA $12.29B
Net Income $4.91B
EPS (Diluted) $3.78
Revenue / Employee $1.6M
Profit / Employee $18.91K
Employees 259,500
Dividends
Annual Dividend $2.66
Dividend Yield 2.95%
Payout Ratio 70.4%
FCF Payout Ratio 28.1%
Adj. FCF Payout Ratio 29.3%
Dividend Growth (YoY) 0.0%
Pay Frequency Quarterly
Ex-Dividend Date Oct 22, 2026
Add to Watchlist
Select watchlists to add or remove CVS